Can recycling your own blood during back surgery reduce transfusion risks?
NCT ID NCT07712666
First seen Jul 17, 2026 · Last updated Jul 17, 2026
Summary
This trial investigates whether using a device called a Cell Saver to recycle a patient's own blood during spinal deformity surgery is safe and reduces the need for donor blood transfusions. About 146 adults undergoing major spinal surgery will be randomly assigned to receive either cell salvage or standard care. The study will compare complication rates, blood use, and recovery outcomes between the two groups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intraoperative cell salvage using a Cell Saver device
- What this could lead to
- If cell salvage proves safe and effective, it could reduce reliance on donor blood transfusions and lower complication rates in major spinal surgery.
- What could go wrong
- This is a relatively small, early-stage trial, and previous research suggests salvaged red blood cells may be a poor substitute for donor blood, potentially increasing complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT SPINAL DEFORMITY SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.